Asset Details
Do you wish to reserve the book?
Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment
Do you wish to request the book?
Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment
2010
Overview
Abstract
Acute lung injury (ALI) remains a significant source of morbidity and mortality in the critically ill patient population. Defined by a constellation of clinical criteria (acute onset of bilateral pulmonary infiltrates with hypoxemia without evidence of hydrostatic pulmonary edema), ALI has a high incidence (200,000 per year in the US) and overall mortality remains high. Pathogenesis of ALI is explained by injury to both the vascular endothelium and alveolar epithelium. Recent advances in the understanding of pathophysiology have identified several biologic markers that are associated with worse clinical outcomes. Phase III clinical trials by the NHLBI ARDS Network have resulted in improvement in survival and a reduction in the duration of mechanical ventilation with a lung-protective ventilation strategy and fluid conservative protocol. Potential areas of future treatments include nutritional strategies, statin therapy, and mesenchymal stem cells.
Publisher
SAGE Publications,Mary Ann Liebert,Mary Ann Liebert, Inc
Subject
Acute Lung Injury - epidemiology
/ Acute Lung Injury - etiology
/ Acute respiratory distress syndrome
/ Animals
/ Biological and medical sciences
/ Humans
/ Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
/ Mesenchymal Stem Cell Transplantation
/ Pharmaceutical technology. Pharmaceutical industry
/ Pharmacology. Drug treatments
/ Prevalence studies (Epidemiology)
/ Statins
